Tigan (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Tigan drug offered from Par Pharmaceutical, Inc.. This Antiemetic [EPC],Emesis Suppression [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | trimethobenzamide hydrochloride |
SUBSTANCE NAME: | TRIMETHOBENZAMIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiemetic [EPC],Emesis Suppression [PE] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-08-01 |
END MARKETING DATE: | 0000-00-00 |
Tigan HUMAN PRESCRIPTION DRUG Details:
Item Description | Tigan from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2008-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42023-118_1db64ec1-3939-4756-a44b-00c90005ce05 |
PRODUCT NDC: | 42023-118 |
APPLICATION NUMBER: | NDA017530 |
Other TRIMETHOBENZAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: